Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-26T10:08:12.908Z Has data issue: false hasContentIssue false

Chapter 2 - The Business Landscape of Men’s Health

from Section 1 - An Introduction to Men’s Health Care

Published online by Cambridge University Press:  06 December 2023

By
James M. Weinberger  and
Jesse N. Mills
Edited by
Douglas T. Carrell ,
Alexander W. Pastuszak  and
James M. Hotaling
Douglas T. Carrell
Affiliation:
Utah Center for Reproductive Medicine
Alexander W. Pastuszak
Affiliation:
University of Utah
James M. Hotaling
Affiliation:
Utah Center for Reproductive Medicine
Get access

Summary

Given the wide spectrum in practice standards and patterns, array of covered versus out-of-pocket conditions, and role of adjunct streams of revenue, the business landscape of men’s health is diverse. Fundamental to the fiscal success of many providers is the efficacy of direct to consumer marketing in the setting of inelastic demand for solutions to aging, erectile dysfunction (ED), and Peyronie’s disease; this has created enormous markets surrounding supplemental testosterone, online platforms for ED treatment, and out-of-pocket products such as platelet-rich plasma, stem-cell therapy, and shock wave treatments. The contemporary story of men’s health has been defined by the gender health gap; uncovering the link between coronary artery disease (CAD) and ED unveiled a touchpoint for establishing holistic men’s health. University and large hospital systems have the infrastructure to support comprehensive Men’s Health Centers and have therefore maximized the downstream revenue associated with prescriptions, long-term screening, and future hospitalizations.

Keywords

andrologymen’s healthhypogonadismerectile dysfunctionPeyronie’s diseaseinfertilityplatelet-rich plasmastem-cell therapylow intensity shock wave lithotripsy
Type
Chapter
Information
Men's Reproductive and Sexual Health Throughout the Lifespan
An Integrated Approach to Fertility, Sexual Function, and Vitality
 , pp. 8 - 15
Publisher: Cambridge University Press
Print publication year: 2023

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Houman, JJ, Eleswarapu, SV, Mills, JN. Current and future trends in men’s health clinics. Transl Androl Urol. 2020;9(I):S116–S122.CrossRefGoogle ScholarPubMed
Dicker, D, Nguyen, G, Abate, D, et al. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1684–1735.Google Scholar
Tharakan, T, Bettocchi, C, Carvalho, J, et al. Male sexual and reproductive health: does the urologist have a role in addressing gender inequality in life expectancy? Eur Urol Focus. 2019;6.Google Scholar
Landro, L. Why men won’t go to the doctor, and how to change that. Wall Street Journal [Internet]. 2019;1–9. Available from: www.wsj.com/articles/why-men-wont-go-to-the-doctor-and-how-to-change-that-11556590080Google Scholar
Baker, P, Shand, T. Men’s health: time for a new approach to policy and practice? J Glob Health. 2017;7(1).Google Scholar
Inman, BA, St Sauver, JL, Jacobson, DJ, et al. A population-based, longitudinal study of erectile dysfunction and future coronary artery disease. Obstet Gynecol Surv. 2009;64(7):459–460.Google Scholar
Bhasin, S. A perspective on the evolving landscape in male reproductive medicine. J Clin Endocrinol Metab. 2016;101(3):827–836.Google Scholar
Straftis, A, Gray, P. Sex, energy, well-being and low testosterone: an exploratory survey of U.S. men’s experiences on prescription testosterone. Int J Environ Res Public Health. 2019;16.Google Scholar
Marsh, T. Which states fill the most (and fewest) prescriptions for erectile dysfunction drugs?. GoodRx. 2018. Available from: www.goodrx.com/blog/which-states-fill-most-prescriptions-for-erectile-dysfunction-drugs/Google Scholar
Part D Prescriber Data. Centers Medicare Medicaid Serv. 2017. Available from: www.cms.gov/Research-Statistics-Data-and-Systems/Statistics-Trends-and-Reports/Medicare-Provider-Charge-Data/Part-D-PrescriberGoogle Scholar
Layton, JB, Li, D, Meier, CR, et al. Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab. 2014;99(3):835–842.Google Scholar
Baillargeon, J, Kuo, YF, Westra, JR, Urban, RJ, Goodwin, JS. Testosterone prescribing in the United States, 2002–2016. JAMA – J Am Med Assoc. 2018;320(2):200–202.CrossRefGoogle ScholarPubMed
Handelsman, D. Global trends in testosterone prescribing, 2000–2011: expanding the spectrum of prescription drug misuse. Med J Aust. 2013;199:548–551.CrossRefGoogle ScholarPubMed
FDA. Drug Safety Communication: FDA cautions about using testosterone products for low testosterone due to aging. 2015.Google Scholar
Statements G. AUA Guideline TRT. AUA Clin Guide. 2018;(February).Google Scholar
Baillargeon, J, Urban, RJ, Ottenbacher, KJ, Pierson, KS, Goodwin, JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465–1466.CrossRefGoogle ScholarPubMed
Jasuja, GK, Bhasin, S, Rose, AJ. Patterns of testosterone prescription overuse. Curr Opin Endocrinol Diabetes Obes. 2017;24(3):240–245.Google Scholar
Epifanova, MV, Gvasalia, BR, Durashov, MA, Artemenko, SA. Platelet-rich plasma therapy for male sexual dysfunction: myth or reality? Sex Med Rev. 2020;8(1):106–113.Google Scholar
Shahinyan, RH, Amighi, A, Carey, AN, et al. Direct-to-consumer internet prescription platforms overlook crucial pathology found during traditional office evaluation of young men with erectile dysfunction. Urology. 2020;143:165–172.CrossRefGoogle ScholarPubMed
Imprialos, K, Koutsampasopoulos, K, Manolis, A, Doumas, M. Erectile dysfunction as a cardiovascular risk factor: time to step up?. Curr Vasc Pharmacol. 2021;19(3):301–312.CrossRefGoogle ScholarPubMed
Dong, J, Zhang, Y, Qin, L. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol. 2011;58(13):1378–1385.Google Scholar
Global Erectile Dysfunction Drugs Market Growth 2019–2024. Mark. Study Rep. 2019.Google Scholar
Erectile dysfunction devices therapies market to be worth over $645 million by 2023. Arizton Advisory & Intelligence. January 12, 2018. Available from: www.arizton.com/news/press-release/erectile-dysfunction-devices-therapies-market. Accessed November 11, 2022.Google Scholar
Carrier, S. Platelet rich plasma: what’s the evidence for efficacy in ED/PD?. Nashville: 2019. Available from: www.smsna.org/nashville2019/presentations/122.pdfGoogle Scholar
Burnett, AL, Nehra, A, Breau, RH, et al. AUA Guideline ED. AUA Clin Guidel 2018;(April):1–36.Google Scholar
Liu, JL, Chu, KY, Gabrielson, AT, et al. Restorative therapies for erectile dysfunction: position statement from the Sexual Medicine Society of North America (SMSNA). Sex Med. 2021;9:100343.CrossRefGoogle ScholarPubMed
Allday, E. Merchants of hope. SF Chron. 2018. Available from: https://projects.sfchronicle.com/2018/stem-cells/clinics/Google Scholar
Zarembo, A. Clinic settles lawsuits but still faces scrutiny over erectile dysfunction injections. Los Angeles Times. 2011. Available from: www.latimes.com/local/education/la-xpm-2011-apr-07-la-me-boston-medical-20110404-story.htmlGoogle Scholar
Farr, C. How men’s health start-ups are turning erectile dysfunction and hair loss treatment into a booming business. CNBC. 2019. Available from: www.cnbc.com/2019/11/17/hims-aims-to-raise-200-million-as-sales-of-mens-health-products-grow.htmlGoogle Scholar
Nehra, A, Alterowitz, R, Culkin, DJ, et al. Peyronie’s disease: AUA guideline. J Urol. 2016;194(3):745–753.Google Scholar
Krieger, JR, Rizk, PJ, Kohn, TP, Pastuszak, A. Shockwave therapy in the treatment of Peyronie’s disease. Sex Med Rev. 2019;7(3):499–507.CrossRefGoogle ScholarPubMed
Gomez de Diego, E. The therapies of Peyronie’s disease are an unclear business in 2019. NewsWire. 2019. Available from: www.newswire.com/news/the-therapies-of-peyronies-disease-are-an-unclear-business-in-2019-20812142Google Scholar
Culha, M, Erkan, E, Cay, T, Yucetas, U. The effect of platelet-rich plasma on Peyronie’s disease in rat model. Urol Int. 2019;102(2):218–223.Google Scholar
Hatzimouratidis, K, Eardley, I, Giuliano, F, Moncada, I, Salonia, A. European Association of Urology Guidelines on Penile Curvature. 2015.Google Scholar
Hilton, L. Shock wave therapy: ED cure or unproven treatment? [Internet]. Urol. Times. 2019. Available from: www.urologytimes.com/view/shock-wave-therapy-ed-cure-or-unproven-treatmentGoogle Scholar
Dupree, JM. Insurance coverage of male infertility: what should the standard be? Transl Androl Urol. 2018;7(Suppl 3):S310–S316.Google Scholar
De Jonge, C, Barratt, CLR. The present crisis in male reproductive health: an urgent need for a political, social, and research roadmap. Andrology. 2019;7(6):762–768.Google Scholar
Levine, H, Jørgensen, N, Martino-Andrade, A, et al. Temporal trends in sperm count: a systematic review and meta-regression analysis. Hum Reprod Update. 2017;23(6):646–659.Google Scholar
Elliott, PA, Hoffman, J, Abad-Santos, M, Herndon, C, Katz, PP, Smith, JF. Out of pocket costs of male infertility care and associated financial strain. Urol Pract. 2016;3(4):256–261.Google Scholar
Fertility Clinics & Infertility Services Industry. Res. Mark. 2020. Available from: www.researchandmarkets.com/reports/5028546/fertility-clinics-and-infertility-services?utm_source=dynamic&utm_medium=GNOM&utm_code=z9m4dj&utm_campaign=1392804+-+Insights+into+the+Fertility+Clinics+%26+Infertility+Services+Industry+in+the+US+to+2025+-+Featuring+Allan+Guttmacher+Institute%2C+California+Cryobank+%26+Cryos+International+Among+Others&utm_exec=jamu273gnomdGoogle Scholar
Kolettis, P, Sabanegh, E. Significant medical pathology discovered during a male infertility evaluation. J Urol. 2001;166:178–180.Google Scholar
Loizos, C. Newly funded Legacy, a sperm testing and freezing service, conveys a message to men: get checked. Yahoo Financ. 2020. Available from: https://finance.yahoo.com/news/legacy-sperm-testing-freezing-just-211742168.html?bcmt=1Google Scholar
Dupree, JM, Dickey, RM, Lipshultz, LI. Inequity between male and female coverage in state infertility laws. Fertil Steril [Internet]. 2016;105(6):1519–1522.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×